861857-60-5

Upstream product

• 36282-40-3 (3-methoxyphenyl)magnesium bromide 
• 729559-16-4 N-cyclohexylidene-2-methylpropane-2-sulfinamide 

Downstream Products

• 125802-07-5 1-(3-methoxyphenyl)cyclohexan-1-amine 
• 125802-06-4 1-(3-methoxyphenyl)-cyclohexylamine hydrochloride 

Relevant academic research and scientific papers

METHODS OF TREATMENT OF AMYLOIDOSIS USING ASPARTYL-PROTEASE INHIBITORS

The invention relates to acetyl 2-hydroxy-1,3-diaminospirocyclohexanes and derivatives thereof that are useful in treating diseases, disorders, and conditions associated with amyloidosis. Amyloidosis refers to a collection of diseases, disorders, and conditions associated with abnormal deposition of A-beta protein.

SUBSTITUTED UREA AND CARBAMATE, PHENACYL-2-HYDROXY-3-DIAMINOALKANE, AND BENZAMIDE-2-HYDROXY-3-DIAMINOALKANE ASPARTYL-PROTEASE INHIBITORS

The invention relates to acetyl 2-hydroxy-1,3-diaminospirocyclohexanes and derivatives thereof that are useful in treating at least one disease, disorder, and condition associated with amyloidosis. Amyloidosis refers to a collection of diseases, disorders, and condition associated with abnormal deposition of A-beta protein.